INVESTIGATING SAFETY AND PRELIMINARY EFFICACY OF AFM13 PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE. (12th June 2019) - Ansell, S.M.; Bartlett, N.L.; Chen, R.W.; Herrera, A.; Domingo‐Domenech, E.; Mehta, A.; Forero‐Torres, A.; Garcia‐Sanz, R.; Armand, P.; Devata, S.; Rodriguez Izquierdo, A.; Lossos, I.S.; et al.